Literature DB >> 25931426

TRAF2 regulates peripheral CD8(+) T-cell and NKT-cell homeostasis by modulating sensitivity to IL-15.

Jeanette E Villanueva1, Elisabeth K Malle1, Sandra Gardam2, Pablo A Silveira3, Nathan W Zammit1, Stacey N Walters1, Robert Brink2, Shane T Grey1.   

Abstract

In this study, a critical and novel role for TNF receptor (TNFR) associated factor 2 (TRAF2) is elucidated for peripheral CD8(+) T-cell and NKT-cell homeostasis. Mice deficient in TRAF2 only in their T cells (TRAF2TKO) show ∼40% reduction in effector memory and ∼50% reduction in naïve CD8(+) T-cell subsets. IL-15-dependent populations were reduced further, as TRAF2TKO mice displayed a marked ∼70% reduction in central memory CD8(+) CD44(hi) CD122(+) T cells and ∼80% decrease in NKT cells. TRAF2TKO CD8(+) CD44(hi) T cells exhibited impaired dose-dependent proliferation to exogenous IL-15. In contrast, TRAF2TKO CD8(+) T cells proliferated normally to anti-CD3 and TRAF2TKO CD8(+) CD44(hi) T cells exhibited normal proliferation to exogenous IL-2. TRAF2TKO CD8(+) T cells expressed normal levels of IL-15-associated receptors and possessed functional IL-15-mediated STAT5 phosphorylation, however TRAF2 deletion caused increased AKT activation. Loss of CD8(+) CD44(hi) CD122(+) and NKT cells was mechanistically linked to an inability to respond to IL-15. The reduced CD8(+) CD44(hi) CD122(+) T-cell and NKT-cell populations in TRAF2TKO mice were rescued in the presence of high dose IL-15 by IL-15/IL-15Rα complex administration. These studies demonstrate a critical role for TRAF2 in the maintenance of peripheral CD8(+) CD44(hi) CD122(+) T-cell and NKT-cell homeostasis by modulating sensitivity to T-cell intrinsic growth factors such as IL-15.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CD8+ T cell; Homeostasis; IL-15; NKT cell; TRAF2; TRAF3

Mesh:

Substances:

Year:  2015        PMID: 25931426     DOI: 10.1002/eji.201445416

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Targeted deletion of Traf2 allows immunosuppression-free islet allograft survival in mice.

Authors:  Jeanette E Villanueva; Stacey N Walters; Mitsuru Saito; Elisabeth K Malle; Nathan W Zammit; Katherine A Watson; Robert Brink; Nicole L La Gruta; Stephen I Alexander; Shane T Grey
Journal:  Diabetologia       Date:  2017-01-06       Impact factor: 10.122

Review 2.  TRAF family molecules in T cells: Multiple receptors and functions.

Authors:  Tina Arkee; Gail A Bishop
Journal:  J Leukoc Biol       Date:  2019-11-21       Impact factor: 4.962

3.  Integrated proteogenomic characterization of urothelial carcinoma of the bladder.

Authors:  Ning Xu; Zhenmei Yao; Guoguo Shang; Dingwei Ye; Haixing Wang; Hailiang Zhang; Yuanyuan Qu; Jun Hou; Fujiang Xu; Yunzhi Wang; Zhaoyu Qin; Jiajun Zhu; Fan Zhang; Jinwen Feng; Sha Tian; Yang Liu; Jianyuan Zhao; Jianming Guo; Yingyong Hou; Chen Ding
Journal:  J Hematol Oncol       Date:  2022-06-03       Impact factor: 23.168

4.  TRAF2 regulates T cell immunity by maintaining a Tpl2-ERK survival signaling axis in effector and memory CD8 T cells.

Authors:  Xiaoping Xie; Lele Zhu; Zuliang Jie; Yanchuan Li; Meidi Gu; Xiaofei Zhou; Hui Wang; Jae-Hoon Chang; Chun-Jung Ko; Xuhong Cheng; Shao-Cong Sun
Journal:  Cell Mol Immunol       Date:  2020-11-17       Impact factor: 22.096

5.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

6.  Comparing the Primary and Recall Immune Response Induced by a New EV71 Vaccine Using Systems Biology Approaches.

Authors:  Jie Shao; Junnan Zhang; Xing Wu; Qunying Mao; Pan Chen; Fengcai Zhu; Miao Xu; Wei Kong; Zhenglun Liang; Junzhi Wang
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

Review 7.  Genetic Alterations of TRAF Proteins in Human Cancers.

Authors:  Sining Zhu; Juan Jin; Samantha Gokhale; Angeli M Lu; Haiyan Shan; Jianjun Feng; Ping Xie
Journal:  Front Immunol       Date:  2018-09-20       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.